Lion Biotechnologies (LBIO) PT Raised to $20 at Chardan Capital Markets, "Leader In Precision Immuno-Oncology"

May 4, 2017 9:34 AM EDT
Get Alerts LBIO Hot Sheet
Price: $6.95 --0%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE

Chardan Capital Markets raised its price target on Lion Biotechnologies (NASDAQ: LBIO) to $20.00 (from $17.50) while maintaining a Buy rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Chardan Capital Markets